CSDCO calls meeting of makers of 19 older FDCs to examine their rationality Dr. Divya Colin18 Jan 2022 4:45 PM ISTNew Delhi: With an aim to understand the rationality of certain older Fixed Dose Combination (FDC) molecules in the market, The Central Drug Standard...
NPPA to study access of medicine at affordable prices, invites proposal Dr. Divya Colin17 Jan 2022 4:15 PM ISTNew Delhi: The apex price regulator authority, National Pharmaceutical Pricing Authority (NPPA) has invited a proposal for conducting a study on "the...
Drug makers to add Itraconazole linked Photosensitivity in package insert: CDSCO panel Medical Dialogues Team16 Jan 2022 11:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Drug makers to include DPP4 inhibitors induced Arthralgia in package insert, says CDSCO panel Medical Dialogues Team15 Jan 2022 5:35 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
WHO panel recommends Eli Lilly Baricitinib, GSK-Vir Biotechnology drug for COVID treatment Ruchika Sharma14 Jan 2022 3:59 PM ISTNew Delhi: The World Health Organization on Friday gave a nod to two new drugs for the treatment of COVID-19 patients with severe and non-severe...
USFDA Warning: Risk of dental problems with Buprenorphine use Ruchika Sharma13 Jan 2022 4:02 PM ISTNew Delhi: The U.S. health regulator on Wednesday warned patients and prescribers about the risk of potential dental problems arising from the use of...
DCGI directs strict vigil on spurious Tocilizumab Injs distribution in India Medical Dialogues Team12 Jan 2022 5:13 PM ISTNew Delhi: Raising a safety alert, the Drugs Controller General of India, Central Drugs Standard Control Organisation (CDSCO) has directed all...
Biocon, Viatris application for Insulin Aspart rejected by USFDA Ruchika Sharma11 Jan 2022 3:30 PM ISTNew Delhi: Biocon Biologics, a subsidiary of biotechnology major Biocon, on Friday said the US health regulator has not approved an application for...
Anti COVID pill Avifavir (Favipiravir) effective against Omicron, Delta, says Russian firm MD Bureau10 Jan 2022 2:40 PM ISTNew Delhi: Russia-based pharma company ChemRar Group on Tuesday announced that its anti-Covid pill, named Avifavir (Favipiravir), is effective against...
Novartis gets CDSCO panel nod to study Alpelisib for early (prophylactic) and sustained improvement of hyperglycemia Medical Dialogues Team9 Jan 2022 8:45 PM ISTNew Delhi: Pharmaceutical major Novartis has got a conditional nod from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Novartis gets CDSCO panel nod to study Ligelizumab in treatment of chronic inducible urticaria Medical Dialogues Team7 Jan 2022 2:21 PM ISTNew Delhi: Pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Molnupiravir has major safety concerns, hence not part of National Protocol: ICMR chief Balram Bhargava Medical Dialogues Bureau6 Jan 2022 11:44 AM ISTNew Delhi: Pointing out to some major saftey concerns including teratogenicity, mutagenicity and also potential to cause cartilage damage and muscle...
